Anthracyclines in the treatment of early breast cancer friend or foe?

Standard chemotherapy for early breast cancer consists generally of an anthracycline – taxane - based regimen, preferably in sequence. Anthracyclines are among the most active cytotoxic drugs against breast cancer. Nevertheless, benefits attained by the use of the more potent anthracycline schedules...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuger, Ana Tecic, Tiscoski, Katsuki, Apolinario, Thiago, Cardoso, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289865/
https://www.ncbi.nlm.nih.gov/pubmed/35839583
http://dx.doi.org/10.1016/j.breast.2022.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289865/
https://www.ncbi.nlm.nih.gov/pubmed/35839583
http://dx.doi.org/10.1016/j.breast.2022.06.007

Ejemplares similares